GTx Inc. (GTXI) Jumped To A 4-Month High On Study Results

GTx Inc. (GTXI) reported positive results from its Phase 2 clinical trial of enobosarm 3 mg Monday morning, in postmenopausal women with stress urinary incontinence.

from RTT - Before the Bell http://ift.tt/2rm9z2Q
via IFTTT